Clinical Trial Results: Positive data from IBIO's clinical trials typically drive the stock price up, while negative results can cause it to fall.

Regulatory Approvals: Receiving FDA or other regulatory approvals for their products would significantly boost investor confidence and the stock price.

Partnerships & Collaborations: Forming strategic alliances with other pharmaceutical companies or research institutions can positively affect the stock price.

Market Sentiment: Overall market conditions and investor sentiment towards the biotechnology sector influence IBIO's stock price.

Financial Performance: IBIO's revenue, expenses, and cash flow can impact investor perception and stock valuation.

Competition: The presence and success of competitors in the same therapeutic areas can put pressure on IBIO's stock.

News & Announcements: Company-specific news releases about new product developments, partnerships, or financial results affect the stock.

Intellectual Property: The strength and scope of IBIO's patents and intellectual property portfolio contribute to its perceived value.

Manufacturing Capacity: IBIO's ability to produce and scale up manufacturing of its products impacts its potential for commercial success.

Management Team: The experience and reputation of IBIO's management team affect investor confidence.